Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 249

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Genistein: Its role in metabolic diseases and cancer

Mukund, Vidya, Mukund, Dhruv, Sharma, Vinay, Mannarapu, Mastan, Alam, Afroz · 2017 · Critical Reviews in Oncology/Hematology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.critrevonc.2017.09.004

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 142

  1. Adlercreutz, 1995, Lignan and isoflavonoid conjugates in human urine, J. Steroid Biochem. Mol. Biol., 52, 97, 10.1016/0960-0760(94)00146-D · DOI · Paper page
  2. Aggarwal, 2009, Inflammation and cancer: how friendly is the relationship for cancer patients?, Curr. Opin. Pharmacol., 9, 351, 10.1016/j.coph.2009.06.020 · DOI · Paper page
  3. Aggarwal, 2006, Molecular targets of dietary agents for prevention and therapy of cancer, Biochem. Pharmacol., 71, 1397, 10.1016/j.bcp.2006.02.009 · DOI · Paper page
  4. Aggarwal, 2016, Suppression of the nuclear factor B activation pathway by spice derived phytochemicals: reasoning for seasoning, Ann. N. Y. Acad. Sci., 434
  5. Aggarwal, 2007, Curcumin: the Indian solid gold, Mol. Targets Ther. Curcumin Health Dis., 1
  6. Andrade, 2010, Absolute bioavailability of isoflavones from soy protein isolate-containing food in female BALB/c mice, J. Agric. Food Chem., 58, 4529, 10.1021/jf9039843 · doi:10.1021/jf9039843
  7. Ascencio, 2004, Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats, J. Nutr., 134, 522, 10.1093/jn/134.3.522 · DOI · Paper page
  8. Ballard-Barbash, 1990, Body fate dwistribution and Breast cancer in the framingham study, J. Natl. Cancer Inst., 82, 286, 10.1093/jnci/82.4.286 · DOI
  9. Banerjee, 2008, Multi-targeted therapy of cancer by genistein, Cancer Lett., 269, 226, 10.1016/j.canlet.2008.03.052 · DOI · Paper page
  10. Basak, 2008, Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function, Mol. Cancer Ther., 7, 3195, 10.1158/1535-7163.MCT-08-0617 · DOI
  11. Baud, 2009, Is NF- B a good target for cancer therapy: hopes and pitfalls, Nat. Rev. Drug Discov., 8, 33, 10.1038/nrd2781 · DOI · Paper page
  12. Bazuine, 2005, Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 326, 511, 10.1016/j.bbrc.2004.11.055 · DOI
  13. Bektic, 2005, Molecular effects of the isoflavonoid genistein in prostate cancer, Clin. Genitourin. Cancer, 4, 124
  14. Bergan, 1996, Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-l-integrin, Clin. Exp. Metastasis, 14, 389, 10.1007/BF00123398 · DOI
  15. Budak, 2006, Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system, Fertil. Steril., 85, 1563, 10.1016/j.fertnstert.2005.09.065 · DOI · Paper page
  16. Busby, 2002, Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men, Am. J. Clin. Nutr., 75, 126, 10.1093/ajcn/75.1.126 · DOI · Paper page
  17. Cassidy, 2006, Factors affecting the bioavailability of soy isoflavones in humans, J. AOAC Int., 89, 1182, 10.1093/jaoac/89.4.1182 · DOI
  18. Chang, 1995, Metabolism of daidzein and genistein by intestinal bacteria, J. Nat. Prod., 58, 1892, 10.1021/np50126a014 · DOI · Paper page
  19. Chang, 2000, Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats, J. Nutr., 130, 1963, 10.1093/jn/130.8.1963 · DOI · Paper page
  20. Choi, 2009, Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats, Nutrition, 25, 676, 10.1016/j.nut.2008.11.027 · DOI
  21. Cohen, 1999, Apoptosis: mechanisms of life and death in the immune system, J. Allergy Clin. Immunol., 103, 548, 10.1016/S0091-6749(99)70222-8 · DOI
  22. Coldham, 2000, Pharmacokinetics of [14C] genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health, Toxicol. Appl. Pharmacol., 164, 206, 10.1006/taap.2000.8902 · DOI · Paper page
  23. Coldham, 2002, Absolute bioavailability of [14C] genistein in the rat; plasma pharmacokinetics of parent compound, genistein glucuronide and total radioactivity, Eur. J. Drug Metab. Pharmacokinet., 27, 249, 10.1007/BF03192335 · DOI
  24. Cornwell, 2004, Dietary phytoestrogens and health, Phytochemistry, 65, 995, 10.1016/j.phytochem.2004.03.005 · DOI · Paper page
  25. Harris, 2009, Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung, Inflammopharmacology, 17, 55, 10.1007/s10787-009-8049-8 · DOI · Paper page
  26. Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6 · DOI · Paper page
  27. Davis, 1999, Genistein inhibits NF-kB activation in prostate cancer cells, Nutr. Cancer, 35, 167, 10.1207/S15327914NC352_11 · DOI · Paper page
  28. Eferl, 2003, AP-1: a double-edged sword in tumorigenesis, Nat. Rev. Cancer, 3, 859, 10.1038/nrc1209 · DOI · Paper page
  29. El Touny, 2009, Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis, Cancer Res., 69, 3695, 10.1158/0008-5472.CAN-08-2958 · DOI
  30. El-Rayes, 2006, Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor- B, Cancer Res., 66, 10553, 10.1158/0008-5472.CAN-06-2333 · DOI
  31. Farina, 2006, Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls, Prenat. Diagn., 26, 1115, 10.1002/pd.1562 · DOI
  32. Ferenc, 2010, Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells, J. Photochem. Photobiol., B, 98, 25, 10.1016/j.jphotobiol.2009.10.004 · DOI
  33. Fisher, 2006, Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma, J. Clin. Oncol., 24, 4867, 10.1200/JCO.2006.07.9665 · DOI · Paper page
  34. Ford, 2005, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US, Diabetes Care, 28, 2745, 10.2337/diacare.28.11.2745 · DOI · Paper page
  35. Friedl, 2003, Tumour-cell invasion and migration: diversity and escape mechanisms, Nat. Rev. Cancer, 3, 362, 10.1038/nrc1075 · DOI · Paper page
  36. Genistin, 1941, (An isoflavone glucoside) and its aglucone, genistein, from soybeans, J. Am. Chem. Soc., 63, 3273, 10.1021/ja01857a013 · DOI
  37. Genolet, 2004, PPARs as drug targets to modulate inflammatory responses?, Curr. Drug Targets-Inflammation Allergy, 3, 361, 10.2174/1568010042634578 · DOI
  38. Gescher, 1998, Suppression of tumour development by substances derived from the diet—mechanisms and clinical implications, Br. J. Clin. Pharmacol., 45, 1, 10.1046/j.1365-2125.1998.00640.x · DOI
  39. Gong, 2003, Inactivation of NF- B by genistein is mediated via Akt signaling pathway in breast cancer cells, Oncogene, 22, 4702, 10.1038/sj.onc.1206583 · DOI · Paper page
  40. Gu, 2006, Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women, J. Nutr., 136, 1215, 10.1093/jn/136.5.1215 · DOI · Paper page
  41. Gu, 2009, Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma, World J. Gastroenterol., 15, 4952, 10.3748/wjg.15.4952 · DOI
  42. Hämäläinen, 2007, Mediators Inflamm., 2007, 1, 10.1155/2007/45673 · DOI · Paper page
  43. Hillman, 2004, Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model, Mol. Cancer Ther., 3, 1271, 10.1158/1535-7163.1271.3.10 · DOI
  44. Huang, 2005, Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells, Cancer Res., 65, 3470, 10.1158/0008-5472.CAN-04-2807 · DOI · Paper page
  45. Hur, 2002, Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein, Arch. Microbiol., 178, 8, 10.1007/s00203-002-0414-6 · DOI
  46. Ismail, 2007, Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation, Eur. J. Pharmacol., 575, 12, 10.1016/j.ejphar.2007.07.039 · DOI
  47. Izukawa, 2009, Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers, Drug Metab. Dispos., 37, 1759, 10.1124/dmd.109.027227 · DOI · Paper page
  48. Jawaid, 2010, Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors, J. Steroid Biochem. Mol. Biol., 120, 164, 10.1016/j.jsbmb.2010.04.007 · DOI
  49. Jinno, 2003, Functional characterization of cytochrome P450 2B6 allelic variants, Drug Metab. Dispos., 31, 398, 10.1124/dmd.31.4.398 · DOI
  50. Jonas, 1995, Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets, Br. J. Pharmacol., 114, 872, 10.1111/j.1476-5381.1995.tb13285.x · DOI
  51. Kaefer, 2008, The role of herbs and spices in cancer prevention, J. Nutr. Biochem., 19, 347, 10.1016/j.jnutbio.2007.11.003 · DOI · Paper page
  52. Kano, 2006, Bioavailability of isoflavones after ingestion of soy beverages in healthy adults, J. Nutr., 136, 2291, 10.1093/jn/136.9.2291 · DOI · Paper page
  53. Ke, 2006, Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell, Cell Div
  54. Kikuno, 2008, Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells, Int. J. Cancer, 123, 552, 10.1002/ijc.23590 · DOI · Paper page
  55. Kim, 2009, Nuclear cyclin D1: an oncogenic driver in human cancer, J. Cell. Physiol., 220, 292, 10.1002/jcp.21791 · DOI · Paper page
  56. Kim, 2014, Absolute configuration of (−)-2-(4-hydroxyphenyl) propionic acid: stereochemistry of soy isoflavone metabolism, Bull. Korean Chem. Soc., 35, 1883, 10.5012/bkcs.2014.35.6.1883 · DOI
  57. Kim, 2014, Chiroptical study and absolute configuration of (–)–O-DMA produced from daidzein metabolism, Chirality, 26, 434, 10.1002/chir.22295 · DOI
  58. Kim, 2001, Actions of the soy phytoestrogen genistein in models of human chronic disease: potential involvement of transforming growth factor beta, Biochem. Soc. Trans., 29, 216, 10.1042/bst0290216 · DOI
  59. Kim, 2004, Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR [alpha], Mol. Cell. Endocrinol., 220, 51, 10.1016/j.mce.2004.03.011 · DOI · Paper page
  60. Kim, 2009, Genistein inhibits cell growth by modulating various mitogen activated protein kinases and AKT in cervical cancer cells, Ann. N. Y. Acad. Sci., 1171, 495, 10.1111/j.1749-6632.2009.04899.x · DOI
  61. King, 1998, Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans, Am. J. Clin. Nutr., 67, 867, 10.1093/ajcn/67.5.867 · DOI · Paper page
  62. King-Batoon, 2008, Modulation of gene methylation by genistein or lycopene in breast cancer cells, Environ. Mol. Mutagen., 49, 36, 10.1002/em.20363 · DOI · Paper page
  63. Kousidou, 2006, Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells, Mini Rev. Med. Chem., 6, 331, 10.2174/138955706776073420 · DOI
  64. Krammer, 1998, CD95 (APO-1/Fas)-mediated apoptosis: live and let die, Adv. Immunol., 71, 163, 10.1016/S0065-2776(08)60402-2 · DOI · Paper page
  65. Kuhn, 2007, Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma, Blood, 110, 3281, 10.1182/blood-2007-01-065888 · DOI · Paper page
  66. Kumi-Diaka, 2006, Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells, J. Med. Food, 9, 491, 10.1089/jmf.2006.9.491 · DOI
  67. Kurkela, 2003, Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs) UGT1A9 is more resistant to detergent inhibition than the other UGTS and was purified as an active dimeric enzyme, J. Biol. Chem., 278, 3536, 10.1074/jbc.M206136200 · DOI
  68. Kyle, 1997, Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity, Mol. Pharmacol., 51, 193, 10.1124/mol.51.2.193 · DOI · Paper page
  69. Larkin, 2008, The key importance of soy isoflavone bioavailability to understanding health benefits, Crit. Rev. Food Sci. Nutr., 48, 538, 10.1080/10408390701542716 · DOI · Paper page
  70. Lee, 2011, Soybean isoflavone genistein regulates apoptosis through NF-[kappa] B dependent and independent pathways, Exp. Toxicol. Pathol.
  71. Lee, 2008, Histone deacetylase inhibitors in cancer therapy, Curr. Opin. Oncol., 20, 639, 10.1097/CCO.0b013e3283127095 · DOI
  72. Li, 2002, Inhibition of nuclear factor B activation in PC3 cells by genistein is mediated via Akt signaling pathway, Clin. Cancer Res., 8, 2369
  73. Liu, 2000, Endothelial cell survival and apoptosis in the tumor vasculature, Apoptosis, 5, 323, 10.1023/A:1009679307513 · DOI
  74. Liu, 2009, Targeting the phosphoinositide 3-kinase pathway in cancer, Nat. Rev. Drug Discov., 8, 627, 10.1038/nrd2926 · DOI · Paper page
  75. Mackowiak, 1999, Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats, J. Recept. Signal Transduct., 19, 283, 10.3109/10799899909036651 · doi:10.3109/10799899909036651
  76. Maffeis, 2007, Fat cell size, insulin sensitivity, and inflammation in obese children, J. Pediatr., 151, 647, 10.1016/j.jpeds.2007.04.053 · DOI
  77. Masharani, 2009, Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects, Metabolism, 58, 1602, 10.1016/j.metabol.2009.05.012 · DOI
  78. Matarese, 2002, Balancing susceptibility to infection and autoimmunity: a role for leptin?, Trends Immunol., 23, 182, 10.1016/S1471-4906(02)02188-9 · DOI · Paper page
  79. Matthews, 2007, AP-1 a target for cancer prevention, Curr. Cancer Drug Targets, 7, 317, 10.2174/156800907780809723 · DOI
  80. Meng, 2009, Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity, Cancer Res., 69, 573, 10.1158/0008-5472.CAN-08-2088 · DOI · Paper page
  81. Mesiano, 1999, Phytoestrogens alter adrenocortical function: genistein and daidzein suppress glucocorticoid and stimulate androgen production by cultured adrenal cortical cells, J. Clin. Endocrinol. Metab., 84, 2443
  82. Mi kus, 2007, Genistein inhibits the contact-stimulated migration of prostate cancer cells, Cell. Mol. Biol. Lett., 12, 348
  83. Mitsiades, 2004, Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors, Cancer Cell, 5, 221, 10.1016/S1535-6108(04)00050-9 · DOI · Paper page
  84. Mommsen, 1999, Cortisol in teleosts: dynamics, mechanisms of action, and metabolic regulation, Rev. Fish Biol. Fish., 9, 211, 10.1023/A:1008924418720 · DOI · Paper page
  85. Morris, 1999, In vitro and in vivo effects of genistein on murine alveolar macrophage TNF production, Inflammation, 23, 231, 10.1023/A:1020221919154 · DOI · Paper page
  86. Mueller, 2004, Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor (ER) and ER in human cells, Toxicol. Sci., 80, 14, 10.1093/toxsci/kfh147 · DOI · Paper page
  87. Nagaraju, 2011, Reproductive regulators in decapod crustaceans: an overview, J. Exp. Biol., 214, 3, 10.1242/jeb.047183 · DOI · Paper page
  88. Nakamura, 2009, A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy, Mol. Cancer, 8, 100, 10.1186/1476-4598-8-100 · DOI
  89. Nauclér, 2002, Signaling to localized degranulation in neutrophils adherent to immune complexes, J. Leukoc. Biol., 71, 701, 10.1189/jlb.71.4.701 · DOI
  90. Nielsen, 2007, Review of the factors affecting bioavailability of soy isoflavones in humans, Nutr. Cancer, 57, 1, 10.1080/01635580701267677 · DOI · Paper page
  91. Nilsson, 1998, [beta] A novel estrogen receptor offers the potential for new drug development, Trends Endocrinol. Metab., 9, 387, 10.1016/S1043-2760(98)00096-4 · DOI
  92. Niwa, 2013, Effect of the genistein metabolite on leptin secretion in murine adipocytes in vitro, Food Chem., 138, 122, 10.1016/j.foodchem.2012.09.108 · DOI
  93. Nogowski, 2002, The influence of coumestrol, zearalenone, and genistein administration on insulin receptors and insulin secretion in ovariectomized rats, J. Recept. Signal Transduct., 22, 449, 10.1081/RRS-120014613 · doi:10.1081/rrs-120014613
  94. Oh, 2010, Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor, Biochem. Biophys. Res. Commun., 393, 319, 10.1016/j.bbrc.2010.01.133 · DOI
  95. Ohno, 2003, Electron transfer process of poly (ethylene oxide)-modified cytochrome c in imidazolium type ionic liquid, Chem. Lett., 32, 450, 10.1246/cl.2003.450 · doi:10.1246/cl.2003.450
  96. Okuno, 1998, Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats, J. Clin. Invest., 101, 1354, 10.1172/JCI1235 · DOI · Paper page
  97. Ouyang, 2009, Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways, Cell Biol. Int., 33, 1237, 10.1016/j.cellbi.2009.08.011 · DOI
  98. Overall, 2006, Towards third generation matrix metalloproteinase inhibitors for cancer therapy, Br. J. Cancer, 94, 941, 10.1038/sj.bjc.6603043 · DOI · Paper page
  99. Page-McCaw, 2007, Matrix metalloproteinases and the regulation of tissue remodelling, Nat. Rev. Mol. Cell Biol., 8, 221, 10.1038/nrm2125 · DOI · Paper page
  100. Park, 2010, Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma, Cancer Lett., 292, 54, 10.1016/j.canlet.2009.11.004 · doi:10.1016/j.canlet.2009.11.004
  101. Park, 2011, Stereospecific microbial production of isoflavanones from isoflavones and isoflavone glucosides, Appl. Microbiol. Biotechnol., 91, 1173, 10.1007/s00253-011-3310-7 · DOI
  102. Peng, 2010, Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis, Eur. J. Cancer Prev., 19, 110, 10.1097/CEJ.0b013e3283362a3e · DOI
  103. Penza, 2006, Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner, Endocrinology, 147, 5740, 10.1210/en.2006-0365 · DOI · Paper page
  104. Perraudin, 1993, Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors, J. Clin. Endocrinol. Metab., 76, 1522
  105. Pike, 1999, Estrogen modulates neuronal bcl xl expression and amyloid induced apoptosis, J. Neurochem., 72, 1552, 10.1046/j.1471-4159.1999.721552.x · DOI · Paper page
  106. Polak, 2006, mTORC2 caught in a SINful Akt, Developmental cell, 11, 433, 10.1016/j.devcel.2006.09.005 · DOI
  107. Puli, 2006, Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones, J. Neurooncol., 79, 135, 10.1007/s11060-006-9126-0 · DOI
  108. Raffoul, 2006, Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest, BMC Cancer, 6, 107, 10.1186/1471-2407-6-107 · DOI · Paper page
  109. Ramos, 2007, Entamoeba histolytica: apoptosis induced in vitro by nitric oxide species, Exp. Parasitol., 116, 257, 10.1016/j.exppara.2007.01.011 · DOI
  110. Ramos, 2007, Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention, J. Nutr. Biochem., 18, 427, 10.1016/j.jnutbio.2006.11.004 · DOI · Paper page
  111. Relic, 2009, Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts, Lab. Invest., 89, 811, 10.1038/labinvest.2009.41 · doi:10.1038/labinvest.2009.41
  112. Sarkar, 2006, Using chemopreventive agents to enhance the efficacy of cancer therapy, Cancer Res., 66, 3347, 10.1158/0008-5472.CAN-05-4526 · DOI · Paper page
  113. Sawai, 2005, Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation, Mol. Cancer, 4, 37, 10.1186/1476-4598-4-37 · DOI
  114. Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J. Nutr., 131, 1362S, 10.1093/jn/131.4.1362S · DOI · Paper page
  115. Sethi, 2009, Potential pharmacological control of the NF-[kappa] B pathway, Trends Pharmacol. Sci., 30, 313, 10.1016/j.tips.2009.03.004 · DOI · Paper page
  116. Sethi, 2008, Nuclear factor-{kappa} B activation: from bench to bedside, Exp. Biol. Med., 233, 21, 10.3181/0707-MR-196 · DOI · Paper page
  117. Shelnutt, 2000, Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein, Cancer Epidemiol. Prev. Biomark., 9, 413
  118. Shelnutt, 2002, Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage, Am. J. Clin. Nutr., 76, 588, 10.1093/ajcn/76.3.588 · DOI · Paper page
  119. Sieg, 2000, FAK integrates growth-factor and integrin signals to promote cell migration, Nat. Cell Biol., 2, 249, 10.1038/35010517 · DOI · Paper page
  120. Skogseth, 2006, The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase, APMIS, 114, 61, 10.1111/j.1600-0463.2006.apm_230.x · DOI
  121. Smith, 1993, Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin, Arch. Biochem. Biophys., 300, 238, 10.1006/abbi.1993.1033 · doi:10.1006/abbi.1993.1033
  122. Stephenson, 2003, Breast cancer and obesity: an update, Nutr. Cancer, 45, 1, 10.1207/S15327914NC4501_1 · DOI · Paper page
  123. Su, 2009, Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates–catenin signaling in mammary epithelial cells, Carcinogenesis, 30, 331, 10.1093/carcin/bgn279 · DOI
  124. Szkudelska, 2007, Genistein–a dietary compound inducing hormonal and metabolic changes, J. Steroid Biochem. Mol. Biol., 105, 37, 10.1016/j.jsbmb.2007.01.005 · DOI
  125. Taylor, 2009, The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies, Nutr. Rev., 67, 398, 10.1111/j.1753-4887.2009.00213.x · DOI · Paper page
  126. Upadhyay, 2001, Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21WAF1, Clin. Cancer Res., 7, 1782
  127. Valle, 2010, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer, New Engl. J. Med., 362, 1273, 10.1056/NEJMoa0908721 · DOI · Paper page
  128. Verdrengh, 2003, Genistein as an anti-inflammatory agent, Inflamm. Res., 52, 341, 10.1007/s00011-003-1182-8 · DOI · Paper page
  129. Wang, 2008, Osteopontin: role in immune regulation and stress responses, Cytokine Growth Fact. Rev., 19, 333, 10.1016/j.cytogfr.2008.08.001 · DOI · Paper page
  130. Wang, 2010, Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy, Mini Rev. Med. Chem., 10, 1058, 10.2174/1389557511009011058 · DOI
  131. Wang, 2010, Down regulation of Notch 1 and Jagged 1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF B signaling pathways, J. Cell. Biochem., 109, 726, 10.1002/jcb.22451 · DOI · Paper page
  132. Wannamethee, 2005, Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus, Arch. Intern. Med., 165, 2644, 10.1001/archinte.165.22.2644 · DOI · Paper page
  133. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  134. Xu, 2006, Mol. Pharmacol., 70, 869, 10.1124/mol.106.023861 · DOI
  135. Yamauchi, 2003, Competitive interactions of chlorinated phenol compounds with 3, 3', 5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water, Toxicol. Appl. Pharmacol., 187, 110, 10.1016/S0041-008X(02)00045-5 · doi:10.1016/s0041-008x(02)00045-5
  136. Yan, 2010, Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways, Proteomics, 10, 976, 10.1002/pmic.200900662 · DOI
  137. Yang, 2010, Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC–MS/MS method: application to an oral bioavailability study of genistein in mice, J. Pharm. Biomed. Anal., 53, 81, 10.1016/j.jpba.2010.03.011 · doi:10.1016/j.jpba.2010.03.011
  138. Yellayi, 2003, The phytoestrogen genistein suppresses cell-mediated immunity in mice, J. Endocrinol., 176, 267, 10.1677/joe.0.1760267 · DOI
  139. Yu, 2010, Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation, Med. Oncol., 1
  140. Zhang, 2010, Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-[kappa] B, Anticancer Drugs, 21, 288, 10.1097/CAD.0b013e328334da17 · DOI
  141. Zhang, 2011, Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines, PLoS One, 6, e23831, 10.1371/journal.pone.0023831 · DOI
  142. Zhou, 2008, Dose-dependent absorption, metabolism, and excretion of genistein in rats, J. Agric. Food Chem., 56, 8354, 10.1021/jf801051d · DOI

Cited by

See all 249

Metadata

Authors
Mukund, V., Mukund, D., Sharma, V., Mannarapu, M., & Alam, A.
Venue
Critical Reviews in Oncology/Hematology
Publisher
Elsevier BV
Published
2017-11
Volume
119
Pages
13-22
ISSN
1040-8428 (ISSN-L)
OpenAlex
W2755129520
Cited by
249
References
13
FWCI
14.28
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genistein: Its role in metabolic diseases and cancer. https://app.cochat.ai/papers/10.1016/j.critrevonc.2017.09.004
The paper
Mukund, V., Mukund, D., Sharma, V., Mannarapu, M., & Alam, A. (2017). Genistein: Its role in metabolic diseases and cancer. Critical Reviews in Oncology/Hematology. https://doi.org/10.1016/j.critrevonc.2017.09.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.